Business & Finance
Dendreon reports second quarter net loss of $18.8 million
Published in Medical Letter on the CDC and FDA, September 10th, 2006
Revenue for the second quarter of 2006 was $78,000 compared to $58,000 for the quarter ended June 30, 2005. Revenue for the six months ended June 30, 2006 was $103,000 compared to $115,000 for the six months ended June 30, 2005.
Dendreon's total operating expenses for the second quarter of 2006 were $20.1 million compared to $18.7 million in 2005. Dendreon's total operating expenses for the six months ended June 30, 2006 were $45.6 million compared to $39.4 million for the same period in 2005. Operating expenses for the three and six months ended June 30, 2006 included...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Addiction Medicine
Methamphetamine injections increase dopamine turnover - Human Papillomavirus
Cytobrush samples can be used for detection of HPV but not for determining viral load - Nuclear Medicine
Radioactive Drug Research Committee regulations need updating - Q Fever Epidemiology
Epidemiology of human Q fever in United States is reported - Vector-Borne Disease
Egyptian fleas with public health significance were surveyed - Addiction Medicine
GABA-mimetic drugs differently affect cocaine-evoked hyperlocomotion and sensitization - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
